Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-fos induction in limited brain areas

Neuroendocrinology

Volumn 101, Issue 1, 2015, Pages 35-44

  Maejima, Yuko ^a,b   Rita, Rauza Sukma ^a   Santoso, Putra ^a   Aoyama, Masato ^c   Hiraoka, Yuichi ^d   Nishimori, Katsuhiko ^d   Gantulga, Darambazar ^a   Shimomura, Kenju ^a,b   Yada, Toshihiko ^a,e  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c UTSUNOMIYA UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Dorsal motor nucleus of vagus; Glucose tolerance; Insulin release; Nasal treatment; Obesity; Oxytocin; Paraventricular nucleus

Indexed keywords

GLUCOSE; INSULIN; OXYTOCIN; PROTEIN C FOS; GLUCOSE BLOOD LEVEL; PROTEIN C JUN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FOOD INTAKE; GENE INDUCTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOREACTIVITY; INSULIN RELEASE; LOCOMOTION; MALE; MEDULLA OBLONGATA; MEDULLARY ARCUATE NUCLEUS; MOTONEURON NUCLEUS; MOUSE; NERVE CELL; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; VAGUS NERVE; ANIMAL; BRAIN; C57BL MOUSE; DRUG EFFECTS; EATING; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MOTOR ACTIVITY;

ADMINISTRATION, INTRANASAL; ANIMALS; BLOOD GLUCOSE; BRAIN; EATING; GLUCOSE TOLERANCE TEST; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURONS; OXYTOCIN; PROTO-ONCOGENE PROTEINS C-JUN;

EID: 84926418593     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000371636     Document Type: Article

References (51)

1. Kiss A, Mikkelsen JD: Oxytocin-Anatomy and functional assignments: a minireview. Endocr Regul 2005; 39: 97-105.
2. Donaldson ZR, Young LJ: Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008; 322: 900-903.
3. Neumann ID, Landgraf R: Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 2012; 35: 649-659.
4. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher, Fehr E: Oxytocin increases trust in humans. Nature 2005; 435: 673-676.
5. Feldman R, Weller A, Zagoory-Sharon O, Levine A: Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding. Psychol Sci 2007; 18: 965-970.
6. Jin D, Liu HX, Hirai H, Torashima T, Nagai T, Lopatina O, Shnayder NA, Yamada K, Noda M, Seike T, Fujita K, Takasawa S, Yokoyama S, Koizumi K, Shiraishi Y, Tanaka S, Hashii M, Yoshihara T, Higashida K, Islam MS, Yamada N, Hayashi K, Noguchi N, Kato I, Okamoto H, Matsushima A, Salmina A, Munesue T, Shimizu N, Mochida S, Asano M, Higashida H: CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 2007; 446: 42-45.
7. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TH, Dietrich MO, Tanaka S, Dezaki K, Oh-I S, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T: Nesfatin-1-regulated oxytocinergic signalling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 2009; 10: 355-365.
8. Olson BR, Drutarosky MD, Chow MS, Hruby VJ, Stricker EM, Verbalis JG: Oxytocin and oxytocin agonist administered centrally decrease food intake in rats. Peptides 1991; 12: 113-118.
9. Arletti R, Benelli A, Bertolini A: Oxytocin inhibits food intake and fluid intake in rats. Physiol Behav 1990; 48: 825-830.
10. Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, Nishimori K: Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 2008; 9: 951-955.
11. Camerino C: Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) 2009; 17: 980-984.
12. Ogden CL, Kit BK, Carroll MD, Flegal KM: Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307: 483-490.
13. Bardou M, Barkun AN, Martel M: Obesity and colorectal cancer. Gut 2013; 62: 933-947.
14. Suplicy H, Boguszewski CL, Dos Santos CM, do Desterro de Figueiredo M, Cunha DR, Radominski R: A comparative study of five centrally acting drugs on the pharmacological treatment of obesity. Int J Obes (Lond) 2014; 38: 1097-1103.
15. Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T: Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging (Albany NY) 2011; 3: 1169-1177.
16. Zhang H, Wu C, Chen Q, Chen X, Xu Z, Wu J, Cai D: Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One 2013; 8: 1-11.
17. Ott V, Finlayson G, Lehnert H, Heitmann B, Heinrichs M, Born J, Hallschmid M: Oxytocin reduces reward-driven food intake in humans. Diabetes 2013; 62: 3418-3425.
18. Shimomura K, Galvanovslis J, Goldsworthy M , Hugill A, Kaizak S, Lee A, Meadows N, Quwailid MM, Rydström J, Teboul L, Ashcroft F, Cox RD: Insulin secretion from betacells is affected by deletion of nicotinamide nucleotide transhydrogenase. Methods Enzymol 2009; 457: 451-480.
19. Neumann ID, Maloumby R, Beiderbeck DI, Lukas M, Landgraf R: Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 2013; 38: 1985-1993.
20. Ramos L, Hicks C, Caminer A, McGregor IS: Inhaled vasopressin increases sociability and reduces body temperature and heart rate in rats. Psychoneuroendocrinology 2014; 46: 46-51.
21. Mens WB, Witter A, Van Wismersm Greidanus TB: Penetration of neurophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res 1983; 262: 143-149.
22. Banks WA, Kastin AJ: Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci 1996; 59: 1923-1943.
23. Ludwig M, Tobin VA, Callahan MF, Papadaki E, Becker A, Engelmann M, Leng G: Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression. Neural activity and behavioral performance of rats. J Neuroendocrinol 2013; 25: 655-667.
24. Bridges TE, James NV: The hypothalamoneurohypophysial system of native Australian desert rodents. The vasopressin and oxytocin contents of hypothalamus and posterior pituitary of Notomys alexis and Pseudomys australis compared with those of the laboratory rat and mouse in different states of water balance. Aust J Exp Biol Med Sci 1982; 60: 265-283.
25. Swanson LW, Sawchenko PE: Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983; 6: 269-324.
26. Xu Y, Wu Z, Sun H, Zhu Y, Kim ER, Lowell BB, Arenkiel BR, Xu Y, Tong Q: Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation. Cell Metab 2013; 18: 860-870.
27. Schwartz MW, Woods SC, Porte D Jr., Seeley RJ, Baskin DG: Central nervous system control of food intake. Nature 2000; 404: 661-671.
28. Putheti RR, Patil MC, Obire O: Nasal drug delivery in pharmaceutical and biotechnology: present and future. J Sci Technol 2009; 4: 1-21.
29. Gould BR, Zingg HH: Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-lacZ reporter mouse. Neuroscience 2003; 122: 155-168.
30. Stein MK, Loewy AD: Area postrema projects to FoxP2 neurons of the pre-locus and parabranchial nuclei: brainstem sites implicated in sodium appetite regulation. Brain Res 2010; 1359: 116-127.
31. Browning KN, Travagli RA: Plasticity of vagal brainstem circuits in the control of gastrointestinal function. Auton Neurosci 2011; 161: 6-13.
32. Welch MG, Tamir H, Gross KJ, Chen J, Anwar M, Gershon MD: Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the entric nervous system (ENS) and intestinal epithelium. J Comp Neurol 2009; 512: 265-270.
33. Cormier HC, Della-Maggiore V, Karatsoreos IN, Koletar MM, Ralph MR: Suprachiasmatic vasopressin and the circadian regulation of voluntary locomotor behavior. Eur J Neurosci 2015; 41: 79-88.
34. Zhang G, Cai D: Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment. Am J Physiol Endocrinol Metab 2011; 301:E1004-E1012.
35. Moos F, Freund-Mercier MJ, Guerné Y, Guerné JM, Stoeckel ME, Richard P: Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilitatory effect of oxytocin on its own release. J Endocrinol 1984; 102: 63-72.
36. Neumann I, Koehler E, Landgraf R, Summy-Long J: An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats. Endocrinology 1994; 134: 141-148.
37. Kawarabayashi T, Kuriyama K, Nakashima T, Kiyohara T, Sugimori H: Oxytocin modulates oxytocin neurons in the paraventricular nuclei of female rats throughout pregnancy and parturition. Am J Obstet Gynecol 1993; 168: 969-974.
38. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719.
39. Iwasaki Y, Shimomura K, Kohno D, Dezaki K, Ayush EA, Nakabayashi H, Kubota N, Kadowaki T, Kakei M, Nakata M, Yada T: Insulin activates vagal afferent neurons including those innervating pancreas via insulin cascade and Ca 2+ influx: its dysfunction in IRS2-KO mice with hyperphagic obesity. PLoS One 2013; 8:e67198.
40. Altszuler N, Hampshire J: Intranasal instillation of oxytocin increases insulin and glucagon secretion. Proc Soc Exp Biol Med 1981; 168: 123-124.
41. Schwartz MW, Seeley RJ, Tschop MH, Woods SC, Morton GJ, Myers MG, D'Alesso D: Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 2013; 503: 59-66.
42. Björkstrand E, Eriksson M, Uvnäs-Moberg K: Evidence of a peripheral and a central effect of oxytocin on pancreatic hormone release in rats. Neuroendocrinology 1996; 63: 377-383.
43. Douglas AJ, Johnstone LE, Leng G: Neuroendocrine mechanisms of change in food intake during pregnancy: a potential role for brain oxytocin. Physiol Behav 2007; 24: 352-365.
44. Makarova EN, Kochubei ED, Bazhan NM: Regulation of food consumption during pregnancy and lactation in mice. Neurosci Behav Physiol 2010; 40: 263-267.
45. Argiolas A, Melis MR: The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol Behav 2004; 83: 309-317.
46. Young KA, Liu Y, Gobrogge KL, Wang H, Wang Z: Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine. J Neurosci 2014; 34: 8499-8506.
47. Love TM: Oxytocin, motivation and the role of dopamine. Pharmacol Biochem Behav 2014; 119: 49-60.
48. Gimpl G, Fahrenholz F: The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81: 629-683.
49. McGregor IS, Bowen MT: Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm Behav 2012; 61: 331-339.
50. Morales-Rivera A, Hernández-Burgos MM, Martínez-Rivera A, Pérez-Colón J, Rivera R, Montalvo J, Rodríguez-Borrero E, Maldonado-Vlaar CS: Anxiolytic effects of oxytocin in cue-induced cocaine seeking behavior in rats. Psychopharmacology (Berl) 2014; 231: 4145-4155.
51. Kenny PJ: Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 2011; 12: 638-651.